Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Aurinia Pharmaceuticals Inc. buy melinda

Aurinia Pharmaceuticals Inc.
Start price
€5.11
16.03.18 / 50%
Target price
€9.92
17.09.18
Performance (%)
-0.53%
End price
€5.09
17.09.18
Summary
This prediction ended on 17.09.18 with a price of €5.09. During the runtime of the prediction for Aurinia Pharmaceuticals Inc. the price only changed by -0.53%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Aurinia Pharmaceuticals Inc. -2.427% -2.427% -55.059% -54.971%
iShares Core DAX® 2.594% -1.861% 13.242% 16.867%
iShares Nasdaq 100 3.553% -2.064% 38.293% 45.898%
iShares Nikkei 225® 0.687% -8.704% 17.510% 2.760%
iShares S&P 500 2.209% -1.988% 27.632% 42.955%

Comments by melinda for this prediction

In the thread Aurinia Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -0.53%
Target price 9.922
Change
Ends at 17.09.18

Biotechnologie und Medizintechnik SecteurRecherche Agenda 15/03 Ergebnisse Veröffentlichung



Beruf
Logo Aurinia Pharmaceuticals Dans
Arbeitet als biopharmazeutisches Unternehmen, das sich auf die Entdeckung und Entwicklung von immunmodulierende Therapeutika konzentriert

Aurinia Pharmaceuticals, Inc. betreibt als pharmazeutisches Unternehmen im klinischen Stadium, die bei der Entwicklung eines therapeutischen Arzneimittels greifen Autoimmunerkrankungen zu behandeln, besonders Lupus Nephritis.

Das Unternehmen wurde von Robert Foster, Richard Glickman und Michael Martin Juni 1993 16, gegründet und ist in Victoria, Kanada.



melinda 
0
Report Share
16.03.18
Prediction Buy
Perf. (%) -0.53%
Target price 9.922
Change
Ends at 17.09.18

(Laufzeit überschritten)

melinda 
0
Report Share
17.09.18

Stopped prediction by melinda for Aurinia Pharmaceuticals Inc.

buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.60
02.05.23
€12.00
02.05.24
-20.19%
27.08.23

melinda 
02.05.23 10%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.20
01.12.19
-
04.11.21
283.75%
05.11.21

melinda 
01.12.19 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.49
30.11.18
€5.86
03.12.18
6.82%
03.12.18

melinda 
18.08.19 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.72
14.09.17
€6.77
19.12.17
-26.81%
19.12.17

melinda 
14.08.19 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.34
14.09.17
€7.50
19.12.17
-26.81%
19.12.17

melinda 
14.08.19 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.34
17.02.17
€3.74
02.03.17
48.68%
02.03.17

melinda 
14.08.19 50%